hydroxyurea has been researched along with Graft vs Host Disease in 15 studies
Graft vs Host Disease: The clinical entity characterized by anorexia, diarrhea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the GRAFT VS HOST REACTION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To analyze the results of idarubicin (IDA)- versus etoposide (VP16)-intensified myeloablative conditioning regimen in allogeneic hematopoietic stem cell transplantation (allo-SCT) for high-risk acute leukemia." | 7.75 | A comparative study of outcomes of idarubicin- and etoposide-intensified conditioning regimens for allogeneic peripheral blood stem cell transplantation in patients with high-risk acute leukemia. ( Chen, ZC; Li, L; Li, QB; Xia, LH; You, Y; Zou, P, 2009) |
| "To analyze the results of idarubicin (IDA)- versus etoposide (VP16)-intensified myeloablative conditioning regimen in allogeneic hematopoietic stem cell transplantation (allo-SCT) for high-risk acute leukemia." | 3.75 | A comparative study of outcomes of idarubicin- and etoposide-intensified conditioning regimens for allogeneic peripheral blood stem cell transplantation in patients with high-risk acute leukemia. ( Chen, ZC; Li, L; Li, QB; Xia, LH; You, Y; Zou, P, 2009) |
| "Acute and chronic pain as well as end-organ damage occur throughout the lifespan of individuals living with SCD resulting in significant disease morbidity and a median life expectancy of 43 years in the USA." | 2.82 | Advances in the diagnosis and treatment of sickle cell disease. ( Brandow, AM; Liem, RI, 2022) |
| "The management of chronic myeloid leukemia (CML) patients who relapse after allogeneic bone marrow transplantation (BMT) is difficult." | 2.38 | Chronic myeloid leukemia: management of relapse after allogeneic bone marrow transplantation. ( Kumar, L, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.67) | 18.7374 |
| 1990's | 3 (20.00) | 18.2507 |
| 2000's | 9 (60.00) | 29.6817 |
| 2010's | 1 (6.67) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Brandow, AM | 1 |
| Liem, RI | 1 |
| Abraham, A | 1 |
| Cluster, A | 1 |
| Jacobsohn, D | 1 |
| Delgado, D | 1 |
| Hulbert, ML | 1 |
| Kukadiya, D | 1 |
| Murray, L | 1 |
| Shenoy, S | 1 |
| Li, QB | 1 |
| Li, L | 1 |
| You, Y | 1 |
| Chen, ZC | 1 |
| Xia, LH | 1 |
| Zou, P | 1 |
| Brachet, C | 1 |
| Azzi, N | 1 |
| Demulder, A | 1 |
| Devalck, C | 1 |
| Gourdin, A | 1 |
| Gulbis, B | 1 |
| Klein, A | 1 |
| Le, PQ | 1 |
| Loop, M | 1 |
| Sariban, E | 1 |
| Ferster, A | 1 |
| Gaziev, J | 1 |
| Sodani, P | 1 |
| Polchi, P | 1 |
| Andreani, M | 1 |
| Lucarelli, G | 1 |
| Kumar, L | 1 |
| Leber, B | 1 |
| Walker, IR | 1 |
| Rodriguez, A | 1 |
| McBride, JA | 1 |
| Carter, R | 1 |
| Brain, MC | 1 |
| Sureda, A | 1 |
| Hernández-Bronchud, M | 1 |
| Brunstein, CG | 1 |
| Mcglave, PB | 1 |
| Eming, SA | 1 |
| Peters, T | 1 |
| Hartmann, K | 1 |
| Scharffetter-Kochanek, K | 1 |
| Mahrle, G | 1 |
| Hambach, L | 1 |
| Eder, M | 1 |
| Dammann, E | 1 |
| Battmer, K | 1 |
| Stucki, A | 1 |
| Heil, G | 1 |
| Ganser, A | 1 |
| Hertenstein, B | 1 |
| Wassmann, B | 1 |
| Klein, SA | 1 |
| Scheuring, U | 1 |
| Pfeifer, H | 1 |
| Martin, H | 1 |
| Gschaidmeier, H | 1 |
| Hoelzer, D | 1 |
| Ottmann, OG | 1 |
| Yoshida, M | 1 |
| Arnulf, B | 1 |
| Chebbi, F | 1 |
| Lefrere, F | 1 |
| Ait Arkoub, Z | 1 |
| Varet, B | 1 |
| Fillet, AM | 1 |
| Ostendorf, P | 1 |
| Ehninger, G | 1 |
| Schmidt, H | 1 |
| Haen, M | 1 |
| Link, H | 1 |
| Schüch, K | 1 |
| Müller, C | 1 |
| Wernet, P | 1 |
| Dopfer, H | 1 |
| Klingebiel, T | 1 |
6 reviews available for hydroxyurea and Graft vs Host Disease
| Article | Year |
|---|---|
Advances in the diagnosis and treatment of sickle cell disease.
Topics: Anemia, Sickle Cell; Chronic Pain; Graft vs Host Disease; Hemoglobin, Sickle; Humans; Hydroxyurea | 2022 |
Chronic myeloid leukemia: management of relapse after allogeneic bone marrow transplantation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Clinical Trials as Topi | 1993 |
The management of chronic myeloid leukaemia--a case history.
Topics: Adult; Antineoplastic Agents, Alkylating; Biomarkers, Tumor; Bone Marrow Transplantation; Busulfan; | 1997 |
The biology and treatment of chronic myelogenous leukemia.
Topics: Antineoplastic Agents; Benzamides; Busulfan; Clinical Trials as Topic; Combined Modality Therapy; Cy | 2001 |
Donor cell-derived acute myeloid leukemia developing 14 months after matched unrelated bone marrow transplantation for chronic myeloid leukemia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Bone Marrow Transplantation | 2001 |
[Management of complications in patients with chronic myelogenous leukemia].
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Antineoplastic Agents; Graft vs Host Disease; Hematop | 2001 |
1 trial available for hydroxyurea and Graft vs Host Disease
| Article | Year |
|---|---|
Unrelated Umbilical Cord Blood Transplantation for Sickle Cell Disease Following Reduced-Intensity Conditioning: Results of a Phase I Trial.
Topics: Alemtuzumab; Anemia, Sickle Cell; Calcineurin Inhibitors; Child; Child, Preschool; Cord Blood Stem C | 2017 |
8 other studies available for hydroxyurea and Graft vs Host Disease
| Article | Year |
|---|---|
A comparative study of outcomes of idarubicin- and etoposide-intensified conditioning regimens for allogeneic peripheral blood stem cell transplantation in patients with high-risk acute leukemia.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Aspergillus; Busulfan; China; Combine | 2009 |
Hydroxyurea treatment for sickle cell disease: impact on haematopoietic stem cell transplantation's outcome.
Topics: Anemia, Sickle Cell; Antisickling Agents; Child; Child, Preschool; Female; Graft Survival; Graft vs | 2004 |
Bone marrow transplantation in adults with thalassemia: Treatment and long-term follow-up.
Topics: Adolescent; Adult; Azathioprine; Bone Marrow Transplantation; Busulfan; Chelation Therapy; Clinical | 2005 |
Reinduction of remission of chronic myeloid leukemia by donor leukocyte transfusion following relapse after bone marrow transplantation: recovery complicated by initial pancytopenia and late dermatomyositis.
Topics: Adult; Bone Marrow Transplantation; Chronic Disease; Combined Modality Therapy; Dermatomyositis; Fem | 1993 |
Lichenoid chronic graft-versus-host disease-like acrodermatitis induced by hydroxyurea.
Topics: Acrodermatitis; Drug Eruptions; Enzyme Inhibitors; Graft vs Host Disease; Humans; Hydroxyurea; Liche | 2001 |
Hematologic and cytogenetic remission by STI571 (Glivec) in a patient relapsing with accelerated phase CML after second allogeneic stem cell transplantation.
Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Benzamides; Bone Marrow Transplantation; C | 2001 |
Multiple herpes simplex virus infections with various resistance patterns in a matched unrelated donor transplant recipient.
Topics: Acyclovir; Antineoplastic Agents, Alkylating; Antiviral Agents; Bone Marrow Transplantation; Cidofov | 2001 |
[Bone marrow transplantation in chronic myeloid leukemia. Influence of gnotobiotic measures, especially antiviral prophylaxis].
Topics: Acyclovir; Adolescent; Adult; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Cyclos | 1986 |